Thursday, September 15, 2022

Two big admissions regarding Covid vaccines surfaced this week

The director of the Centers for Disease Control and Prevention (CDC) has acknowledged publicly for the first time that the agency gave false information about its COVID-19 vaccine safety monitoring.

Dr. Rochelle Walensky, the agency’s director, said in a letter made public on Sept. 12 that the CDC did not analyze certain types of adverse event reports at all in 2021, despite the agency previously saying it started in February 2021.

“CDC performed PRR analysis between March 25, 2022, through July 31, 2022,” Walensky said. “CDC also recently addressed a previous statement made to the Epoch Times to clarify PRR were not run between February 26, 2021, to September 30, 2021.”

Walensky’s agency had promised in several documents, starting in early 2021, to perform a type of analysis called Proportional Reporting Ratio (PRR) on reports submitted to the Vaccine Adverse Event Reporting System, which it helps manage.

But the agency said in June that it did not perform PRRs. It also said that performing them was “outside th[e] agency’s purview.”

Confronted with the contradiction, Dr. John Su, a CDC official, told The Epoch Times in July that the agency started performing PRRs in February 2021 and “continues to do so to date.”

But just weeks later, the CDC said Su was wrong.

“CDC performed PRRs from March 25, 2022 through July 31, 2022,” a spokeswoman told The Epoch Times in August.

Walensky’s new letter, dated Sept. 2 and sent on Sept. 6 to Sen. Ron Johnson (R-Wis.), shows that Walensky is aware that her agency gave false information.

‘Lacked Any Justification’

Walensky’s letter included no explanation of why that happened.

The letter “lacked any justification for why CDC performed PRRS during certain periods and not others,” Johnson, the top Republican on the Senate Homeland Security and Governmental Affairs Subcommittee on Investigations, told Walensky in a response.

“You also provided no explanation as to why Dr. Su’s assertion … completely contradicts the CDC’s [initial] response … as well as your September 6, 2022, response to me,” he added.

He demanded answers from the CDC on the situation, including why the CDC did not perform PRRs until March and why the agency misinformed the public when it said no PRRs were conducted.

The CDC and Walensky did not respond to requests for comment.

Of course, what can they say to justify lying, especially about the number one issue plaguing America for the past two years?!

But, wait! There’s MORE!

Not only did the CDC lie, but we now have the first undeniable proof linking the vaccine to the myocarditis.

We’ve long reported the many connections between the virus and various ailments, myocarditis among them. Too many stories of teenage athletes, professional athletes, and people in strikingly good health until they took the vaccine emerged almost immediately.

But did our government say “let’s pause, and check this out”? No, of course not. They said “these links to illnesses are lies. These people are fine.” Or, perhaps it was “they had underlying conditions.” I never once heard a leftist say “I’m not comfortable poking more people until we double check their safety.”. Honestly, it’s a damn shame. So many lives, especially young vibrant lives, were lost for no good reason other than to line some corporate pockets. And government pockets, too. Don’t let them pretend to be innocent bystanders here.

The Epoch Times found that a study published in August verified the link between 345 people in England who died of myocarditis in one year were all vaccinated with one of three COVID-19 vaccines.

According to ET:

The study, conducted from December 2020 to December 2021, looked at deaths after a hospital stay for myocarditis or with myocarditis listed as a cause of death on a death certificate among 42.8 million vaccinated people in England age 13 and up.

The publication of the study’s findings in the American Heart Association’s journal, Circulation, marked the first time in the medical literature that researchers have confirmed that myocarditis associated with one of the COVID-19 vaccines can result in death. The article was published online on Aug. 22 and appears in the journal’s September 5, 2022, issue.

“This is really big, to talk about deaths. CDC keeps saying, ‘generally mild, generally mild,” cardiologist Sanjay Verma, who was not involved in the research, told The Epoch Times. “There’s been a concerted campaign to emphasize that people have not died from myocarditis and that it’s generally mild.”

Myocarditis is defined as inflammation of the myocardium, the middle layer of the heart muscle. Although the CDC has acknowledged since the spring of 2021 that myocarditis is a possible side effect of the Pfizer-BioNTech and Moderna vaccines, the agency has not publicly spoken about death as a possible outcome of myocarditis.

The authors of the study in Circulation looked at patient data pulled from the national health database for all those in England age 13 and up who received at least one dose of one of three vaccines available in that country: AstraZeneca, Pfizer-BioNTech, and Moderna.

About 20 million people got the AstraZeneca vaccine, 20 million got the Pfizer vaccine, and just over 1 million got the Moderna vaccine.

The study tracked hospital admissions and deaths from myocarditis by age and gender and in relation to how many doses of each vaccine a person had received. It compared how many cases of myocarditis were associated with a recent SARS-CoV2 infection, and how many were associated with one of the vaccines.

Of the people who received the Pfizer-BioNTech vaccine and were hospitalized for myocarditis or with myocarditis listed on their death certificates, 22 people (17 percent) died within 28 days of receiving the first dose, 14 people (12 percent) died after their second dose, and 13 people (15 percent) died after getting the Pfizer-BioNTech booster.

For the AstraZeneca vaccine, 40 people died of myocarditis after the first dose and 11 after the second dose, 28 percent and 12 percent respectively.

Among those who got the Moderna vaccine, there were no myocarditis deaths within 28 days of vaccination.

The study concluded that, in general, the risk of myocarditis from SARS-CoV2, the virus that causes COVID-19, was greater than the risk of myocarditis from the vaccines. But there was no control group of unvaccinated people, the study was limited to the 28 days following vaccination, and the conclusion did not hold for all ages or all of the vaccines.

For males under 40, the risk of myocarditis after a second dose of the Moderna vaccine was almost four times higher than the risk of myocarditis after a SARS-CoV2 infection, the data showed.

The study is a follow-up to a prior study in which the authors reported an association between the first and second dose of the vaccines and myocarditis.

More Lies!

Neither the CDC nor the FDA has ever acknowledged that any American has died from myocarditis caused by one of the COVID-19 vaccines.

The most recent version of the CDC advisory on adverse events after COVID-19 vaccination said that as of Aug. 31, 2022, there were 1,022 “preliminary reports” of myocarditis and pericarditis for people under 18 in the Vaccine Adverse Event Reporting System (VAERS), and that 672 of them had been verified and had met the CDC’s working definition of myocarditis or pericarditis.

But there is no mention of death as a possible outcome.

“Most patients with myocarditis or pericarditis after COVID-19 vaccination responded well to medicine and rest and felt better quickly,” the advisory said.

A CDC morbidity and mortality report from February 2022 referenced one reported death from myocarditis but offered no confirmation.

“One death was reported; investigation is ongoing, and other contributory factors for myocarditis are being evaluated,” it said.

A CDC advisory on adverse effects of COVID-19 vaccines linked to a January 25, 2022, study in the Journal of the American Medical Association (JAMA), which found that the risk of myocarditis increased after both the Pfizer-BioNTech and Moderna vaccines and was highest after the second dose in adolescents and young men.

The JAMA study alluded to deaths without confirming any, saying that among people under 30, there were “no confirmed cases of myocarditis in those who died after mRNA-based COVID-19 vaccination without another identifiable cause” and that two other deaths “with potential myocarditis” are under investigation.

But once again, did any one shout “Stop the Presses! Let’s get this thing investigated?” Nah, why bother. Leftists would rather just keep lying straight to our faces and hoping we’re too dumb to ever realize that 2 and 2 make 4. Sorry to disappoint you leftists, but we’ve been on to you from the beginning. We’ve always known it was a death poke. Clearly, that’s why I didn’t take one, I sure as heck didn’t let anyone jab my kids, and I tried my best to warn anyone that would listen. I pissed off plenty of people, but I knew they’d thank me later.

Hey guys- it’s later!


First multi-strain COVID-19 vaccine approved for use in Australia after government backs Moderna shot

The federal government has approved a COVID-19 vaccine that specifically targets two coronavirus variants of concern, including the original Omicron strain.

Health Minister Mark Butler said the government had accepted a recommendation from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of a new Moderna vaccine as a booster shot for people aged 18 years and older.

The move marks the first time a multi-strain COVID vaccine — otherwise known as a bivalent vaccine — has been approved for use in Australia.

The new shot is already being used in other countries, including Canada and the United Kingdom.

Unlike other approved vaccines, which only target the original Wuhan strain of the SARS-CoV-2 virus, the bivalent one also targets the original Omicron BA.1 strain.

"This is an important first step in showing how mRNA vaccines can be adapted to different dominant variants and subvariants," Mr Butler said in a statement.

The first doses of the bivalent vaccine have already arrived in the country and will now undergo batch testing by Australia's medical regulator, the Therapeutic Goods Administration (TGA).

They will be introduced into the rollout as existing stocks of Moderna's already-approved COVID-19 vaccine are exhausted.

How effective is it?

The vaccines already in use in Australia provide protection from severe disease against Omicron subvariant infections, but ATAGI found Moderna's bivalent shot provides a modest improvement in the body's immune response.

All jabs provide significant protection from severe disease against Omicron subvariant infections.

Infectious disease physician and microbiologist Paul Griffin, from the University of Queensland, said the approval of the bivalent vaccine did not "detract from how well our original vaccines have worked".

"The virus has continued to change and so we need to update our vaccines accordingly," he said.

Infectious diseases expert Robert Booy said lab data showed this bivalent vaccine was helpful in preventing infection from all Omicron variants, over and above what existing vaccines are expected to provide.

"However we don't know about efficacy because that requires doing a study of many thousands of people, so we have to rely on the immunogenicity, the antibody production," he said.

"And we know that neutralising antibodies with the vaccine are high and protective against the common Omicron strains BA.4 and BA.5."

"But we can see that the vaccine is effective [and] worth having."

Professor Booy also said the bivalent vaccine could be used as a fifth shot in the future. "So if you've had four … you would have had the most recent one within the last few months, and that would protect you until at least Christmas," he said. "So it might be something you do in March or April, at the same time you get your flu jab."

Dr Griffin said it could also help keep Australians safe for some time to come. "The thought there is that it'll get better, broader cross-protection, maybe even against new emerging variants when they do arise," he said.




No comments: